Recent advances in targeting LRRK2 for Parkinson’s disease treatment

Recent advances in targeting LRRK2 for Parkinson’s disease treatment

Abstract Parkinson’s disease (PD) is a neurodegenerative disease with severe movement problems. Current treatments mainly focus on symptom management by reducing dopaminergic pathways in the brain. Despite these therapies, ongoing disease progression undermines the effectiveness of prevalent approac...

Full description

Saved in:
Bibliographic Details
Main Authors: Mahsa Karami, Pantea Majma Sanaye, Atousa Ghorbani, Roshanak Amirian, Pouya Goleij, Mehregan Babamohamadi, Zhila Izadi
Format: Article
Language:English
Published: BMC 2025-07-01
Series:Journal of Translational Medicine
Subjects:
Parkinson’s disease
LRRK2
Neurodegenerative diseases
Autophagy
PROTAC
Mitochondrial dysfunction
Online Access:https://doi.org/10.1186/s12967-025-06354-0
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12967-025-06354-0

Similar Items